S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:RAIN

Rain Therapeutics Insider Trades

$14.72
+0.17 (+1.17 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.47
$15.16
50-Day Range
$12.54
$18.40
52-Week Range
$11.57
$23.90
Volume41,813 shs
Average Volume127,779 shs
Market Capitalization$389.59 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Rain Therapeutics (NASDAQ:RAIN) Insider Buying and Selling Activity

Over the past twelve months, insiders at the have sold shares 2 time(s), totalling $471,023.34. During the same time, Rain Therapeutics insiders have purchased shares 10 time(s), totalling $47,593,524.45. Insiders that have bought shares include Franklin M Berger, Bvf Partners L P/Il, Boxer Capital Llc, Perceptive Advisors Llc, and Boxer Capital Llc.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter


Rain Therapeutics (NASDAQ RAIN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2021Perceptive Advisors LlcMajor ShareholderSell21,826$12.51$273,043.26  
10/7/2021Perceptive Advisors LlcMajor ShareholderSell13,368$14.81$197,980.08  
9/21/2021Franklin M BergerDirectorBuy3,786$14.30$54,139.80  
9/13/2021Bvf Partners L P/IlDirectorBuy392,269$16.49$6,468,515.81  
7/6/2021Bvf Partners L P/IlDirectorBuy269,723$15.25$4,113,275.75  
7/1/2021Bvf Partners L P/IlDirectorBuy317,279$15.65$4,965,416.35  
5/24/2021Bvf Partners L P/IlDirectorBuy1,361$15.90$21,639.90  
5/21/2021Bvf Partners L P/IlDirectorBuy121,986$15.94$1,944,456.84  
5/13/2021Bvf Partners L P/IlDirectorBuy58,000$14.26$827,080.00  
4/27/2021Boxer Capital, LlcDirectorBuy1,025,000$17.00$17,425,000.00  
4/27/2021Perceptive Advisors LlcMajor ShareholderBuy550,000$17.00$9,350,000.00  
4/23/2021Boxer Capital, LlcDirectorBuy150,000$16.16$2,424,000.00120,000  
(Data available from 1/1/2013 forward)












Rain Therapeutics (NASDAQ:RAIN) Insider Trade Frequently Asked Questions

Who is on Rain Therapeutics's Insider Roster?

The list of insiders at Rain Therapeutics includes Boxer Capital, Llc, Bvf Partners L P/Il, Franklin M Berger, and Perceptive Advisors Llc.Learn more on RAIN's insiders

Which Rain Therapeutics insiders have been buying company stock?

The following insiders have purchased Rain Therapeutics stock in the last 24 months: Boxer Capital, Llc ($19,849,000.00), Bvf Partners L P/Il ($18,340,384.65), Franklin M Berger ($54,139.80), and Perceptive Advisors Llc ($9,350,000.00).

How much insider buying is happening at Rain Therapeutics?

Insiders have purchased a total of 2,889,404 Rain Therapeutics shares in the last 24 months for a total of $47,593,524.45 bought.

Which Rain Therapeutics insiders have been selling company stock?

The following insider sold Rain Therapeutics stock in the last 24 months: Perceptive Advisors Llc ($471,023.34).

How much insider selling is happening at Rain Therapeutics?

Insiders have sold a total of 35,194 Rain Therapeutics shares in the last 24 months for a total of $471,023.34 sold.

This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.